Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-05-03Clinical Trial Update: Delayed SLND for Patients With Breast Cancer Undergoing Primary Systemic Treatment
The study evaluating delayed sentinel lymph node dissection in breast cancer patients receiving primary systemic therapy is currently ACTIVE…
-
CLINICAL_TRIALS withdrawal · 2024-05-02Clinical Trial Update: Testing the Addition of Immunotherapy With Hu5F9-G4 (Magrolimab) to the Usual PARP Inhibitor, Olaparib for Treatment of Metastatic or Recurrent Breast or Castrate-Resistant Prostate Cancer With BRCA Mutations [Phase 1]
A Phase 1 trial evaluating the addition of magrolimab to olaparib for BRCA-mutated metastatic breast cancer or castration-resistant prostate…
-
CLINICAL_TRIALS trial_result · 2024-05-01Clinical Trial Update: Analysis of Olaparib Response in Patients With BRCA1 and/or 2 Promoter Methylation Diagnosed of Advanced Breast Cancer [Phase 2]
This Clinical Trials Update reports Phase 2 results for olaparib in patients with BRCA1/2 promoter methylation and advanced breast cancer. R…
-
CLINICAL_TRIALS trial_result · 2024-05-01Clinical Trial Update: A Study to Find the Best Dose of ASP5354 to Show Lymph Nodes in People With Breast Cancer or Melanoma During Surgery [Phase 2]
A Phase 2 study evaluating ASP5354 to visualize sentinel lymph nodes during surgery in breast cancer or melanoma was terminated. Results hav…
-
CLINICAL_TRIALS research · 2024-05-01Clinical Trial Update: Identifying Prognostic Variables for Persistent Upper Limb Dysfunctions After Breast Cancer Treatment
A clinical trial investigating prognostic factors for persistent upper limb dysfunction following breast cancer treatment.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-05-01Clinical Trial Update: Identifying Prognostic Variables for Persistent UL Dysfunctions After Breast Cancer Treatment -Reliability and Validity [NA]
Ongoing KU Leuven study recruiting to identify prognostic variables for persistent upper-limb dysfunction after breast cancer treatment. The…
-
CLINICAL_TRIALS research · 2024-05-01Clinical Trial Update: Label-free Raman Spectroscopy for Discrimination Between Breast Cancer Tumor and Adjacent Tissues After Neoadjuvant Treatment
This clinical trial aims to use label-free Raman spectroscopy to distinguish breast cancer tumor tissue from adjacent non-tumor tissue after…
-
CLINICAL_TRIALS research · 2024-05-01Clinical Trial Update: Relaxation Training by Tele-Rehabilitation in Patients With Breast Cancer [NA]
A clinical trial evaluating relaxation training by tele-rehabilitation for breast cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: Study of Oral Vinorelbine Plus Capecitabine Versus Taxane-gemcitabine Combinations as 1st Line Chemotherapy in Metastatic Breast Cancer [Phase 2]
Phase 2 trial comparing oral vinorelbine plus capecitabine against taxane-gemcitabine combinations as first-line therapy in metastatic breas…
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: A "Window Trial" on Boswellia for Breast Cancer Primary Tumors [Phase 1]
A completed Phase 1 window trial evaluating Boswellia for primary breast cancer tumors. The study was conducted under the auspices of the Me…
-
CLINICAL_TRIALS withdrawal · 2024-04-30Clinical Trial Update: To Assess Efficacy and Safety of Oral Reparixin in Patients With Fatigue and Locally Advanced / Metastatic Breast Cancer [Phase 2]
Phase 2 trial of oral reparixin for fatigue and locally advanced or metastatic breast cancer has been withdrawn.
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: Remote Breast Cancer Screening Study
A remote breast cancer screening trial exploring ultrasound imaging and AI is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: Combination Neoadjuvant Chemotherapy With or Without Apatinib for HER2 Negative Breast Cancer [Phase 2]
This Phase 2 trial assesses neoadjuvant chemotherapy with or without Apatinib for HER2-negative breast cancer.
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: clinIcal Efficacy and Safety of Incadronate in Breast Cancer With Bone Metastases
Clinical trial update on the efficacy and safety of Incadronate in breast cancer with bone metastases. The study is currently recruiting.
-
CLINICAL_TRIALS other · 2024-04-30Clinical Trial Update: Supraclavicular Lymph Node Dissection for Ipsilateral Supraclavicular Lymph Node Metastatic Breast Cancer [NA]
This clinical trial update describes a study evaluating supraclavicular lymph node dissection for breast cancer with ipsilateral supraclavic…
-
CLINICAL_TRIALS research · 2024-04-29Clinical Trial Update: Dynamic and Test-retest Whole Body [18F]FES PET Imaging in Patients With Metastatic ER+ Breast Cancer [NA]
Clinical trial update on whole-body [18F]FES PET imaging for metastatic estrogen receptor-positive breast cancer using dynamic and test-rete…
-
CLINICAL_TRIALS trial_result · 2024-04-29Clinical Trial Update: Health Literacy in Understanding Radiation Therapy Information in Patients Undergoing Definitive Radiation Therapy
The clinical trial NCT04927559 on health literacy in understanding radiation therapy information for patients undergoing definitive radiatio…
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1 and Phase 2 trials evaluated tinengotinib (TT-00420) as a monotherapy and in combination therapy for patients with advanced solid tu…
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: The Treatment of Stage I and II Carcinoma of the Breast With Mastectomy and Axillary Dissection Versus Excisional Biopsy, Axillary Dissection, and Definitive Irradiation [Phase 3]
This Phase 3 trial comparing mastectomy with axillary dissection to excisional biopsy with axillary dissection and definitive irradiation fo…
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Self-applied Acupressure for Arthralgia-fatigue-sleep Disturbance in Breast Cancer [Phase 2]
Phase 2 trial evaluating self-applied acupressure for arthralgia, fatigue, and sleep disturbance in breast cancer patients has been terminat…
-
CLINICAL_TRIALS research · 2024-04-26Clinical Trial Update: The Effect of Appropriate Family Companionship on the Physical and Mental Health of Patients With Advanced Breast Cancer [NA]
This clinical trial explores whether appropriate family companionship improves physical and mental health in patients with advanced breast c…
-
CLINICAL_TRIALS research · 2024-04-25Clinical Trial Update: VR for Surgical Prehabilitation and Rehabilitation [NA]
The study assesses VR-based prehabilitation and postoperative rehabilitation in breast cancer patients; enrollment is by invitation.
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure [NA]
A completed trial evaluated text message nudges delivered before primary care visits to improve closing of care gaps. The study status is co…
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Safety, Tolerability, and Efficacy Study in Subjects With Advanced or Metastatic Breast Cancer [Phase 1]
The Phase 1 trial evaluating safety, tolerability, and preliminary efficacy in advanced or metastatic breast cancer has been terminated. Spo…
-
FDA approval · 2024-04-24FDA Approved: VIJOICE — Original Application (Novartis Pharmaceuticals Corporation)
The FDA approved the original application for VIJOICE (alpelisib) by Novartis for adult patients with HR-positive, HER2-negative advanced or…